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Abstract
Objectives: To estimate HIV prevalence and risk factors in population-based samples of female sex workers (FSW) and
female voluntary counseling and testing (VCT) clients in Rwanda.
Methods: We conducted a cross-sectional survey of 800 FSW and 1,250 female VCT clients in Rwanda, which included
interviewing and testing for HIV-1/2, HSV-2 and pregnancy, and BED-CEIA and Avidity Index (AI) to identify recent infections
among HIV-infected women.
Results: Prevalence of HIV-1, HSV-2, and pregnancy were 24% (95% CI: 21.0–27.0), 59.8% (56.4–63.2), and 7.6% (5.8–9.5)
among FSW, and 12.8% (10.9–14.6), 43.2% (40.4–46.0), and 11.4% (9.7–13.3) among VCT clients, respectively. Thirty-five
percent of FSW and 25% of VCT clients had never been HIV tested. Per national guidelines, 33% of newly HIV-diagnosed
FSW and 36% of VCT clients were already eligible for ART based on CD4,350 cells/ml. Condom use at last sex was higher
among FSW (74%) than VCT clients (12%). In age and district of residence-adjusted models, HIV-1 seropositivity was
associated with HSV-2 co-infection; recent treatment for sexually transmitted infection (STI); genital symptoms; forced sex;
imprisonment; widowhood; and alcohol consumption. Eleven percent of FSW and 12% of VCT clients had recently acquired
HIV-1 per BED-CEIA and AI. HSV-2 infection and recent STI treatment were associated with recent HIV infection in both
groups, and being married and vaginal cleansing were associated with recent infection before last sex among VCT clients.
Conclusions: This population-based survey reveals a high HIV prevalence and incidence among FSW and female VCT clients
in Kigali, the scale of which is masked by the low general-population HIV prevalence in Rwanda. HIV/STI and family planning
services should be strengthened.
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patients receiving sexually transmitted infection (STI) treatment
[1–4]. Several national, population-based surveys have measured
HIV seroprevalence, including a 2005 Demographic and Health
Survey-Plus (DHS+), which found an HIV prevalence of 3%
among adults nationwide, with marked differences in prevalence
by region, age and gender [5]. In the capital city of Kigali,
prevalence was 6.7% among all adults, and 8.0% among adult

Introduction
Accurate and timely information on HIV prevalence and risk
factors, particularly among high-risk groups, is scant in many
developing countries, including Rwanda [1]. Rwanda has
conducted sentinel surveillance of HIV infection since the 1980s,
focusing primarily on women attending antenatal care clinics and
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social networks, some of whom were working as sex workers
themselves (‘‘community mobilizers’’). At recruitment sessions,
women who passed a short pre-screening questionnaire were
invited to the study clinic for a full eligibility assessment. Eligible
women were: $18 years; at high risk for sexual exposure to HIV,
defined as having exchanged sex for money at least once in the last
month; of either unknown HIV serostatus or had a last test that
was negative; and willing and able to provide written informed
consent. The first 800 eligible women who participated in the
survey comprised the final sample.
Female VCT clients. Female VCT clients were recruited
from 11 public HIV testing centers around Kigali city. All female
clients presenting at the center on the designated recruitment day
were screened for study eligibility (based on age $18 years, and
willingness to provide written informed consent) by a study nurse/
counselor. Each VCT site had its own recruitment target based
primarily on clientele volume, and recruitment was conducted
successively across sites until the total sample size of 1,250 was
reached. Sample sizes for both groups were based on estimates of
HIV prevalence, and the projected recruitment targets during the
study period.

women. More than half of HIV-1 seropositive survey participants
(56% of women, 66% of men) had never been HIV tested prior to
the survey [5]. However, while DHS+ provided a good general
population estimate of the burden of and basic factors associated
with HIV in Rwanda, infection rates and risk factors in high-risk,
harder-to-reach sub-groups, such as female sex workers (FSW),
may be substantially higher.
From the standpoint of HIV surveillance, FSW comprise an
important group for monitoring heterosexual transmission of HIV,
in early as well as late-stage epidemics, because they typically have
high prevalence rates and are likely to transmit infection through
frequent, often high-risk sexual contact [6–11]. Sex workers, as a
‘‘most-at-risk-population’’ (MARP), are also a key vulnerable group
for targeted HIV prevention and other public health interventions
[12,13]. However, relatively few countries to date have developed
long-term or community-based prevention programs for FSW,
largely because of the illegality of sex work in many settings. Sex
work is legal in Rwanda, and early serosurveys of FSW in the 1980s
found extremely high rates of HIV infection (75% to nearly 90%)
[14]. However, there has been limited systematic HIV surveillance
in this group since then and, consequently, there are limited data to
describe the current burden of HIV/AIDS among FSW in
Rwanda, particularly from community-based samples [15].
Clients of voluntary counseling and testing (VCT) centers are
another important group from the perspective of HIV surveillance
and primary and secondary prevention [16–18]. VCT is a key
component of HIV prevention and control interventions, and
information about clients’ risk profiles can help inform VCT-based
interventions. Furthermore, clients testing because of HIV exposure, including those in serodiscordant relationships, or perceived
high risk are important groups for reinforcement of prevention
messages. Finally, VCT clients are easily accessible because they
themselves come forward for HIV testing. Despite concerns about
the representativeness of this group compared to the general
population [19], data from VCT clients can nonetheless be an
important source of information on HIV prevalence [20].
We conducted a cross-sectional survey to screen 800 FSW and
1,250 female VCT clients for an HIV incidence study at Projet
Ubuzima, a non-governmental organization for medical research
based in Kigali, Rwanda. The primary aim of the study was apply
and validate tests for early HIV infection. However, an important
secondary aim of the survey was to describe the epidemiology of
HIV in these sentinel groups. This paper presents HIV-1/2
prevalence in the two groups, including the proportion of HIVpositive individuals with recent versus long-term infection (based on
testing by the BED-CEIA and Avidity Index assays); prevalence of
herpes simplex virus type 2 (HSV-2) and pregnancy; demographic
and behavioral characteristics; and a comparison of factors
associated with prevalent and recently acquired HIV infection.

Study procedures
All study procedures for FSW took place at the Projet Ubuzima
study clinic, and sample collection and interviewing for VCT
clients was done onsite at the VCT centers. All participants
provided written informed consent and eligibility was confirmed.
Per the Rwandan National Ethics Committee, individuals aged
18–20 in both groups were required to obtain parental/guardian
consent for study participation. However, as VCT clients would
have had to return the next day with a parent/guardian, we did
not recruit VCT clients aged 18–20. Blood specimens were
collected for HIV, pregnancy and HSV-2 testing. A face-to-face
interview was conducted to collect information on demographics,
medical and reproductive history, including HIV testing history,
partnership status and sexual behavior. Women were given HIV
and pregnancy test results and an appointment card to return to
receive HSV-2 results and CD4 results (if HIV positive).
All HIV testing was accompanied by pre- and post-test
counseling and followed a slightly modified national testing
protocol: a First Response Rapid Test (Premier Medical Corporation, India); if positive, confirmation by Uni-Gold Rapid Test
(Trinity Biotech Plc, Ireland); and Capillus HIV-1/HIV-2 Rapid
Test (Trinity Biotech Plc, Ireland) as a tie-breaker if needed. HIV
rapid test-positive specimens were confirmed by Murex HIV Ag/
Ab Combination ELISA (Abbott Laboratories, Germany); tested by
CD4 cytometry; and tested by the BED-CEIA (BED) assay (Calypte
Biomedical Corporation, USA) [21] and Avidity Index (AI) method
(using the AxSYM ELISA platform, Abbott Laboratories, USA)
[22] to distinguish recent HIV infection (,6 months) from chronic
HIV infection. Blood specimens were also tested by the Fortress
(Fortress Diagnostics, UK) or Orea (Global Diagnostics, UK) hCG
serum pregnancy test, and HSV-2 HerpeSelect 2 ELISA (Focus
Technologies, USA). All testing was done at Projet Ubuzima or the
National Reference Laboratory in Kigali. HIV test results were not
available for 3 VCT clients; CD4 results were not available for 3
FSW and 31 VCT clients; and BED/AI results were not available
for 3 FSW and 5 VCT clients.
Women who tested HIV positive were referred to a local health
center for care and evaluation for treatment eligibility, as well as
psychosocial services. Pregnant women were referred for prenatal
care, and HSV-2 seropositive women were counseled to seek care
in the event of a herpes outbreak. FSW received 4,000 Rwandan
Francs (approximately 7 USD) as compensation for travel to and

Materials and Methods
Ethics statement
All study participants provided written informed consent prior
to study participation. The study was approved by the National
Ethics Committee and the National AIDS Control Commission
(CNLS) in Rwanda, and the Columbia University Medical Center
Institutional Review Board in the United States.

Recruitment, screening and enrollment
Female sex workers. FSW were recruited via community
meetings in 3 Kigali districts, after approval from local authorities.
Meetings were led by Projet Ubuzima outreach staff with
assistance from prominent community members with extensive
PLoS ONE | www.plosone.org
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time spent at the study clinic, and VCT participants received 500
Rwandan Francs (approximately 1 USD) to cover the standard fee
for HIV VCT in Rwanda.

87% of HIV-1-infected FSW and 84% of HIV-1-infected VCT
clients were co-infected with HSV-2 (hereafter, all references to
‘‘HIV’’ refer to HIV-1 infection only, unless otherwise indicated).
Among FSW, there was a positive association between prevalent
HSV-2 and number of years working as a sex worker (age- and
district-adjusted odds ratio [AOR] comparing 6–10 vs. 2 or fewer
years: 1.9 (95% CI: 1.1–3.5)).
Pregnancy prevalence among FSW was 7.6% (95% CI: 5.8–
9.5), with the highest prevalence among women aged 21–24
(10.8%, 95% CI: 7.0–14.6) and lowest among those aged 30–34
(5.0%, 95% CI: 1.1–9.0). Pregnancy prevalence was higher among
VCT clients (overall 11.4% (9.7–13.3)). Sixteen percent of
pregnant FSW and 12% of currently pregnant VCT clients tested
HIV positive in the survey.
Among HIV-positive women with CD4 results available, 42%
of FSW and 38% of VCT clients had a CD4 count $500 cells/ml,
while 12% of FSW and 15% of VCT clients had #200 CD4 cells/
ml (Table 2). Fifteen percent of the total FSW sample and 10% of
the VCT sample reported at least one recent AIDS symptom,
including recent unexpected weight loss, chronic diarrhea, chronic
weakness, fever, cough, night sweats, or oral candidiasis (Table 2).
Among HIV-positive women in both groups, the proportion of
women reporting such symptoms was inversely related to CD4
count. In both groups, HSV-2 co-infection rates decreased with
higher CD4 counts.

Statistical analysis and outcome definitions
Descriptive statistics were used to summarize demographic and
behavioral characteristics of study participants. Categorical
variables are expressed as percentages, and continuous data as
medians and inter-quartile ranges (IQR). HIV, HSV-2 and
pregnancy prevalence were measured as the proportion of
individuals with a positive test result during the survey, and are
presented with 95% confidence intervals (CI) for the binomial
proportion. The Cochran-Armitage trend test was used to
calculate p-values for HIV-1 and pregnancy status by age group,
and the Chi-square test was used to calculate p-values for HIV-1
status by district of residence (Gasabo, Kicukiro, Nyarugenge
combined versus outside Kigali).
Prevalent HIV-1/2 infection was identified by positive HIV
rapid test, with ELISA confirmation. Demographic and behavioral
covariates were analyzed individually in separate logistic regression models, each of which was adjusted for age and district of
residence, to assess their independent association with prevalent
HIV infection, with p-values from the Wilcoxon-Mann-Whitney
test for continuous variables and the Chi-square and Fisher’s exact
tests for categorical variables. Parsimonious models were built for
prevalent infection (versus fully-derived multivariable models) to
enable comparison with results from models for recent infection,
for which there were small numbers of outcomes.
Correlates of recent HIV infection (based on BED and AI assay
results) were assessed individually in separate logistic regression
models that adjusted for age and residence, comparing individuals
with recent HIV infection (RI) to HIV-negative individuals. In
order to maximize specificity, we took a conservative approach for
the risk factor analysis of RI, such that only individuals classified
concordantly as RI on the BED and AI, and with CD4$200 cells/
ml, were considered true RI cases. Samples with discordant assay
classifications, those classified concordantly as RI but with
CD4,200, and those classified concordantly as RI but without
CD4 results, were excluded. Detailed information regarding the
validity of the BED and AI assays has been reported elsewhere
[23]. All tests were two-sided. Analyses were performed in SAS,
version 9.1.3 (SAS Institute, Inc., Cary, NC).

Sociodemographics and contraceptive use
The median age among both FSW and VCT clients was 25
years, with VCT clients slightly older than FSW (Table 3). Overall,
92% of FSW and 45% of VCT clients reported currently using a
modern or traditional (e.g., periodic timed abstinence) contraceptive method, with the majority of users (97% FSW, 68% VCT
clients) reporting modern methods. In both groups, the most
common methods were male condoms and injectable hormonal
methods (80% and 13%, respectively, for FSW; 15% and 10%,
respectively, for VCT clients). FSW had had a median of 2
pregnancies during their lifetimes, with only 7% reporting no
pregnancies; 43% were currently breastfeeding. VCT clients had
had a median of 1 pregnancy during their lifetimes, with 32%
reporting no pregnancies; 24% of VCT clients were currently
breastfeeding.

Marital status, partnerships and sexual behavior

Results

Over one-third (36%) of VCT clients were currently married,
compared with ,1% of FSW. HIV prevalence among married
VCT clients was 14.7%, versus 11.9% among unmarried VCT
clients. Among married VCT clients, 75% had a husband at least
1 year older than they, and 26% of these women had a husband
$10 years older. Twelve percent of FSW and 8% of VCT clients
had been widowed. Among widows, the most common reasons
were war (42% of FSW widows, 36% of VCT widows); AIDS or
other illnesses (26% FSW widows, 40% VCT widows); and motor
vehicle and other accidents (19% FSW widows, 12% VCT
widows).
In addition to paying clients, 23% of FSW had casual (nonpaying) sex partners, and more than one-third (34%) also had a
steady partner (defined as a regular sex partner with whom the
woman has sex more often than with other sex partner(s), but does
not live with and is not married to). Most FSW reported finding
clients at bars/nightclubs (60%) or on the street (47%), and that
sex typically takes place in public places (42%), at clients’ homes
(40%), or the woman’s home (34%). Compared with FSW, fewer
VCT clients had casual (4%) or steady partners (18%).

Screening and enrollment
Prior to the survey, 1,238 FSW were pre-screened by study staff
for potential eligibility; 116 women were determined to be
ineligible because of age ,18 years (n = 14), known HIV-positive
status (n = 85), or low HIV risk (n = 17). The first 800 eligible
women who participated in the survey comprised the final FSW
sample. Data on reasons for ineligibility among the VCT client
sample were not collected.

HIV, HSV-2 and pregnancy prevalence
HIV-1 prevalence was 24.0% (95% CI 21.0–27.0) among FSW,
and 12.8% (10.9–14.6) among VCT clients (Table 1). In both
groups, HIV-1 prevalence significantly increased with age, varied
by district of residence, and among VCT clients, also varied by
testing site. Prevalence of HIV-2 was 0.75% (95% CI: 0.15–1.4)
among FSW, and 1.8% (1.1–2.8) among VCT clients. All HIV-2positive women in both groups were also HIV-1 positive.
Seroprevalence of HSV-2 was 59.8% (95% CI: 56.4–63.2)
among FSW, and 43.2% (40.4–46.0) among VCT clients. Nearly
PLoS ONE | www.plosone.org
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Table 1. Prevalence of HIV, HSV-2 and pregnancy among female sex workers and female VCT clients in Kigali, Rwanda.

Female sex workers (N = 800)

HIV-1

Female VCT clients (N = 1,250)

% (95% CI)

P value

% (95% CI)

P value

24.0 (21.0, 27.0)

NA

12.8 (10.9, 14.6)

NA

HIV-1 by age (in years):
18–20

16.1 (7.0, 25.3)

0

21–24

17.4 (12.8, 22.0)

25–29

23.3 (18.1, 28.5)

11.1 (7.9, 15.0)

30–34

33.6 (25.1, 42.1)

21.4 (15.2, 28.8)

$35

33.7 (24.7, 42.6)

18.2 (13.5, 23.8)

,0.001

8.8 (6.5, 11.5)

,0.001

HIV-1 by district of residence:
Gasabo

24.1 (19.2, 29.1)

Kicukiro

33.2 (27.1, 39.3)

9.7 (7.3, 12.4)

Nyarugenge

16.1 (11.8, 20.5)

17.5 (12.8, 23.1)

Other/outside Kigali

NA

4.1 (0.9, 11.5)

,0.0001

16.2 (12.7, 20.3)

0.02

HIV-1 by VCT site:
Gitega Health Center

15.0 (8.9, 23.5)

ARBEF

12.0 (7.6, 17.8)

Muhima Hospital

16.0 (8.6, 26.3)

Kimironko Health Center
Kacyiru Health Center

21.0 (13.5, 30.3)
NA

14.7 (7.6, 24.7)

Kinyinya Health Center

10.4 (5.7, 17.1)

Kanombe Hospital

20.0 (11.7, 30.8)

Gahanga Health Center

5.3 (1.5, 13.1)

Kicukiro Health Center

15.6 (10.7, 21.8)

L’Association des Guides

3.5 (1.3, 7.4)

Gikondo Health Center

,0.001

13.7 (7.5, 22.3)

HIV-2

0.75 (0.15, 1.4)

NA

1.8 (1.1, 2.8)

NA

HSV-2

59.8 (56.4, 63.2)

NA

43.2 (40.4, 46.0)

NA

Among HIV positive, % HSV-2 infected
Pregnancy by age (in years):

86.8 (82.0, 91.6)

84.3 (77.7, 89.6)

7.6 (5.8, 9.5)

11.4 (9.7, 13.3)

18–20

6.5 (0.3, 12.6)

0

21–24

10.8 (7.0, 14.6)

25–29

6.7 (3.6, 9.8)

30–34

5.0 (1.1, 9.0)

13.0 (8.1, 19.3)

$35

5.6 (1.3, 10.0)

7.2 (4.3, 11.3)

Among currently pregnant women, % HIV+

16.4 (7.1, 25.7)

12.0 (7.7, 19.3)

12.5 (9.8, 15.7)
0.10

11.7 (8.5, 15.7)

0.07

doi:10.1371/journal.pone.0024321.t001

past 6 months (vs. 11% of FSW), and 88% of those with a history
of HIV testing had had their most recent test within the past 2
years (vs. 60% of FSW). In both groups, HIV prevalence rates
were higher among women who had never had an HIV test than
in those who had tested before (35% vs. 18% overall for FSW
(p,0.01), and 18% vs. 11% overall for VCT clients (p,0.01)).
Furthermore, HIV prevalence among FSW who reported a
negative result at their last HIV test was 17.5% (95% CI: 14.2,
20.9), and prevalence was 25.7% (95% CI: 22.6, 28.9) among
FSW who reported not knowing their HIV status at the time of the
survey.

Seventy-four percent of FSW reported their last sex partner
used a condom, versus only 12% of VCT clients. Condom use
with steady partners and husbands was low (50–80% reported
never using condoms) in both groups. Nine and 12% of FSW and
VCT clients, respectively, reported having a current sex partner
they knew to be HIV positive.

HIV testing history
Per the study protocol which included longitudinal follow-up for
FSW only, FSW who had a negative HIV test in the past were
eligible for the study, but only if the most recent test result was
negative; there was no exclusion criterion related to HIV
serostatus for VCT clients who were only screened for participation in the cross-sectional survey. VCT clients reported a more
frequent and recent testing history: 22% had been tested in the
PLoS ONE | www.plosone.org

Factors associated with prevalent and recent HIV
infection among FSW
Factors with the strongest positive associations with prevalent
HIV among FSW after adjusting for age and district of residence
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Table 2. CD4 count distribution among HIV-positive female sex workers and female VCT clients in Kigali, Rwanda.

All women % (N)

% Reporting AIDS symptom
in past 6 months

% Pregnant

% HSV-2 seropositive

,100

4.2 (8)

25.0 (2)

0 (0)

100 (8)

100–199

7.4 (14)

21.4 (3)

0 (0)

93 (13)

200–349

21.1 (40)

22.5 (9)

2.5 (1)

97.5 (39)

350–499

25.3 (48)

20.8 (10)

8.3 (4)

83.3 (40)

$500

41.8 (79)

17.7 (14)

6.3 (5)

81.3 (65)

CD4 range (cells/ml)
Female sex workers (N = 189)

Female VCT clients (N = 128)
,100

3.9 (5)

20.0 (1)

0 (0)

100 (5)

100–199

10.9 (14)

28.6 (4)

21.4 (3)

85.7 (12)

200–349

21.1 (27)

18.5 (5)

7.4 (2)

100 (27)

350–499

26.6 (34)

14.7 (5)

11.8 (4)

82.4 (28)

$500

37.5 (48)

14.6 (7)

10.4 (5)

81.3 (39)

doi:10.1371/journal.pone.0024321.t002

were: HSV-2 infection (AOR 7.9, 95% CI: 4.5–13.8); history of
forced sex (AOR 2.2, 95% CI: 1.5–3.2); and having sought STI
treatment in the previous 3 months (AOR 2.2, 95% CI: 1.3–3.5)
(Table 4). Being widowed, history of imprisonment, alcohol
consumption, having a recent AIDS symptom or genital symptom
(including genital itching, burning, rash, pain; abnormal vaginal
discharge, odor, bleeding; pain or difficulty urinating; genital
ulcers, sores, blisters; pain during sex; acute lower abdominal pain;
other), and vaginal cleansing before last sex were also significantly
positively associated with prevalent HIV infection. Current
breastfeeding and more frequent and recent HIV testing were
associated with decreased odds of prevalent infection.
After excluding women with discordant BED and AI results,
and those with CD4,200 cells/ml and therefore probable longterm infection, 11% (21/190) of HIV-positive FSW were classified
by both the BED-CEIA and AI as having recently acquired HIV
infection (Table 4). After adjusting for age and district of residence,
the odds of recent HIV infection were higher among HSV-2
seropositive women (AOR 17.0, 95% CI: 2.3–128.6) and among
women who recently sought STI treatment (AOR 3.8, 95% CI:
1.4–10.3).
Never having been married, being divorced/separated, condom
use at last sex, frequency of sex, number of clients, and current
pregnancy were not associated with either prevalent or recent HIV
infection among FSW.

After excluding 7 participants from the recent infection group (1
with CD4,200 cells/ml and 6 missing CD4 results), 20 women or
12.4% of HIV-positive VCT clients were classified as having a
recent infection by both the BED-CEIA and AI assays (Table 5).
After adjusting for age and district of residence, the odds of recent
HIV infection were higher among currently married women
(AOR 2.7, 95% CI: 1.1–6.9), women who cleansed the vagina
before their last sexual encounter (AOR3.4, 95% CI: 1.0–11.5),
had $4 HIV tests in their lifetime vs. none (AOR 3.9, 95% CI:
1.0–15.2), and were HSV-2 seropositive (AOR 3.8, 95% CI: 1.7–
8.2). Current breastfeeding, widowhood, history of forced sex,
regular alcohol consumption, and current pregnancy were not
associated with either prevalent or recent HIV infection among
VCT clients.

Discussion
In our community-based sample of FSW in Kigali, overall HIV
prevalence was 24%, and HIV seropositivity rates increased with
age. All positive HIV tests represented first-time diagnoses for
these women, given the exclusion criterion of having a known
positive HIV status. Indeed, prevalence was even higher among
FSW who reported not knowing their HIV status at the time of the
survey (26%). Overall prevalence among FSW in our study is 3
times the 2005 DHS+ estimate of 8.0% HIV prevalence among
women in Kigali [5], although it falls within the general range
reported by other studies among sex workers in the sub-Saharan
region [11,24–30]. It is likely, however, that HIV prevalence
among FSW was underestimated in our study because we
excluded known HIV-positives. Indeed, a recent nationallyrepresentative survey of Rwandan FSW ages 15–49 found an
overall HIV prevalence of 59% (unpublished data, TRAC Plus).
Nonetheless, our survey found evidence of recent HIV acquisition
in this group, with antibody-based incidence assay testing
indicating that 11% of HIV-positive participants were infected
within the past 6 months. The high HIV burden, including
ongoing transmission, justifies scale-up of prevention programs
and systematic surveillance in FSW in Rwanda. HIV-related
interventions and programs should be tailored to sex workers’
needs, for example community-based health education, improved
access to low-cost or free condoms, more widely available clinical
services that integrate HIV testing, care and treatment with other

Factors associated with prevalent and recent HIV
infection among female VCT clients
After adjusting for age and district of residence, having a known
HIV-positive sex partner was the variable that had the largest
association with prevalent HIV infection among VCT clients
(AOR 3.4, 95% CI: 1.6–7.6) (Table 5). In this group, divorced
women had an increased risk of prevalent HIV (AOR 1.8, 95%
CI: 1.1–2.8), while never-married women had a lower risk (AOR
0.6, 95% CI: 0.4–0.9). Similar to FSW, the risk of prevalent
infection among VCT clients decreased with increasing numbers
of HIV tests (AOR 0.3 for $4 vs. 0 lifetime tests, 95% CI: 0.2–
0.6). Increased risk for prevalent HIV was also associated with
HSV-2 seropositivity, history of imprisonment, recent AIDS
symptom or genital symptom, recent STI treatment, and sexual
activity (1–5 partners in the past month vs. none).
PLoS ONE | www.plosone.org
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Table 3. Demographic and behavioral characteristics of female sex workers and female VCT clients, Kigali, Rwanda.

Demographic characteristics

Female sex workers (N = 800)

Female VCT clients (N = 1,250)

Median age, in years (range)

25.0 (18–49)

25.0 (20–68)

18–24

360 (45)

527 (42)

25–29

230 (29)

333 (27)

30–34

114 (14)

154 (12)

$35

96 (12)

236 (19)

166 (21)

194 (16)

Age groups, N(%):

Education level, N(%)
No formal schooling
Some primary school

326 (41)

347 (28)

Completed primary school

207 (26)

386 (32)

Secondary school (partial or completed)

94 (12)

277 (22)

Post-secondary

5 (,1)

26 (2)

Currently using family planning method, N(%)

732 (92)

555 (45)

Median no. lifetime pregnancies (IQR)

2 (1–3)

1 (0–3)

Currently breastfeeding, N(%)

344 (43)

279 (24)

Married (legal or common-law marriage)

4 (1)

452 (36)

Divorced/separated

117 (15)

145 (12)

Widowed

93 (12)

96 (8)

Never married

584 (73)

557 (45)

Marital status, N(%)

Currently have steady partner

275 (34)

220 (18)

797 (99.6)

677 (54)

Received money or gift from partner

744 (93)

23 (2)

Partner used a condom

593 (74)

150 (12)

Median no. vaginal sex acts in past month (IQR)

40 (20–64)

1(0–8)

Median no. different sex partners in last 3 months (IQR)

96 (56–180)

1 (0–1)

Condom use with casual/paying partner, N(%)

(N = 800)

(N = 99)

Vaginal sex in last month, N(%)
At last sex:

Never

11 (1)

50 (51)

Rarely

128 (16)

10 (10)

Half of the time

91 (12)

3 (3)

Most of the time, but not always

403 (50)

16 (16)

Always

167 (21)

20 (20)

(N = 275)

(N = 230)

171 (63)

123 (54)

Rarely

36 (14)

35 (15)

Half of the time

7 (3)

10 (4)

Most of the time, but not always

11 (4)

21 (9)

Always

45 (17)

41 (18)

Condom use with steady partner, N(%)
Never

Condom use with husband, N(%)

(N = 4)

(N = 452)

2 (50)

358 (78)

Rarely

1 (25)

38 (8)

Half of the time

0

10 (2)

Never

Most of the time, but not always

0

10 (2)

Always

1 (25)

40 (9)

Median no. clients per week in last month (IQR)

10 (5–16)

NA

Median years working as sex worker (IQR)

3 (2–5)

NA

Have sex partner known to be HIV positive, N(%)

72 (9)

150 (12)

Ever had forced sex, N(%)

202 (25)

254 (20)

Median no. lifetime HIV tests (IQR)

1 (0–2)

2 (1–3)
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Table 3. Cont.

Demographic characteristics

Female sex workers (N = 800)

Female VCT clients (N = 1,250)

Never tested, N(%)

278 (35)

306 (25)

Once

278 (35)

314 (25)

Twice

115 (14)

264 (21)

3–5 times

106 (13)

300 (24)

$6 times

21 (3)

61 5)

$1 Genital symptom in past month, N(%)

173 (22)

231 (19)

Sought treatment for STI symptom in last 3 months, N(%)

91 (11)

113 (9)

Drink alcohol regularly, N(%)

436 (55)

139 (11)

Ever imprisoned, N(%)

317 (40)

78 (6)

doi:10.1371/journal.pone.0024321.t003

We found a negative association between more frequent and
recent HIV testing and prevalent HIV in both groups. This could
reflect greater likelihood of testing among women with a high
perceived but low actual risk for HIV. Alternatively, testing itself
may confer some protective benefit against infection, for example
promoting safer sexual behavior to maintain a negative serostatus.
However, the cross-sectional study design makes it difficult to
identify specific dynamics related to motivation for HIV testing, as
well as the timing of testing relative to risk behavior. The negative
association between testing history and prevalent HIV risk among
FSW could also reflect selection bias from exclusion of FSW with
known positive HIV serostatus from the study. Furthermore, the
positive association we found between recent HIV infection and
frequent HIV testing among VCT clients may reflect a detection
bias, for example since individuals who test frequently are likelier
to be identified soon after infection [35], and individuals who are
already diagnosed may be less likely to attend VCT. However,
differences in selection criteria for the two groups make
comparison of testing history difficult.
Rwanda’s national ART guidelines [36] recommend initiating
antiretroviral treatment for all individuals with CD4,350 cells/ml
(regardless of AIDS symptoms), as well as for those in the most
advanced clinical disease stage (regardless of CD4 count). Based
on these guidelines, 33% of newly diagnosed FSW (55% of whom
had never been HIV tested), and 36% of newly diagnosed VCT
clients (44% of whom had never been tested before) were already
eligible for treatment because of CD4,350 cells/ml. Furthermore,
the substantial proportion of women (21% FSW, 15% VCT
clients) with CD4 350–499 cells/ml who reported recent AIDS
symptoms suggests potential additional treatment eligibility in this
group. All HIV-positive participants were referred for care and
evaluation for treatment eligibility.
Pregnancy prevalence in both groups was high, and the
substantial proportion of currently breastfeeding women suggests
a high number of recent pregnancies. Despite the fact that HIVinfected FSW were significantly less likely than uninfected FSW to
be currently breastfeeding, there was no significant difference in
median number of lifetime pregnancies or proportion currently
pregnant by HIV status. It is possible that this association between
breastfeeding and HIV infection was confounded by unmeasured
factors. Nonetheless, improved family planning services and
education, including on condoms as a dual protection method,
would benefit these women. While most FSW reported using male
condoms (albeit inconsistently), use among VCT clients was very
low, and there was worrisome inconsistency across partner types in
both groups. Women in both groups were unlikely to use condoms

routine care, targeted HIV testing campaigns that enable earlier
detection of HIV among FSW, and support programs for FSW
living with HIV/AIDS. Although we did not recruit FSW younger
than 18 years, HIV prevalence in the 18–20 year old age group
was already quite high, suggesting the need for education and
prevention efforts targeting younger women. Our study demonstrates that, despite their potential for marginalization, FSW in
Kigali can be enumerated and reached by public health programs.
HIV prevalence was also high among the urban female VCT
clients we surveyed, at nearly 13%. This is more than 4 times the
2005 DHS+ national prevalence estimate of 3%, and almost twice
the DHS’ 8% prevalence among women in Kigali. Meaningful
comparison between our VCT sample and testers from the
Rwanda DHS+ is difficult, principally because only 10% of
women in the DHS+ sample were living in Kigali, and urban/
rural differences persist in Rwanda [1]. This is underscored by
compositional differences on factors related to HIV infection
between the samples (e.g., 48% of DHS+ women were married vs.
36% of our participants). However, HIV prevalence (13%) and the
proportion of women with a recent infection (12%) in our sample
were comparable to other studies among VCT clients in other East
African countries [19,31].
Based on parsimonious models, several factors were positively
associated with prevalent HIV infection in these populations,
including: older age, HSV-2 infection, recent STI treatment,
history of forced sex and imprisonment, AIDS-like symptoms,
widowhood, and alcohol consumption. Two of these factors—
HSV-2 infection and recent STI treatment—were also positively
associated with recent HIV infection in both populations. Among
VCT clients, risk for recent HIV infection was increased among
currently married women, and lower among those who had never
been married. While these associations have been documented by
others [8,32–34], they suggest several possible avenues for
intervention in the Rwandan context, including, for example,
further investigation into the interaction between alcohol use and
sex, expanded prevention and care services for widows, and
perhaps social and legal advocacy related to gender-based
violence. The association in this study between current marriage
and recent HIV infection is difficult to interpret without more
detailed information, for example on the duration and stability of
marriages and risk behavior of partners. Finally, the association
between HIV seropositivity and recent STI treatment suggests
missed opportunities to identify HIV infections at health centers
providing STI services, and therefore a need for better integration
of HIV and STI screening and treatment, especially for at-risk
groups such FSW and their partners.
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Table 4. Factors associated with prevalent and recent HIV infection among female sex workers, Kigali, Rwanda.

Risk factor

No. HIV+
(Total N = 192)

Adjusted Odds
Ratio (95% CI)

P value

No. Recent
Infection
(N = 21)

Adjusted Odds
Ratio (95% CI)

P value

Current age (in years):
18–24

24

– REF –

11

–REF–

25–29

31

1.4 (1.0, 2.2)

0.08

6

0.9 (0.3, 2.5)

30–34

21

2.5 (1.6, 4.0)

,0.001

2

0.7 (0.2, 3.4)

0.69

$35

19

2.4 (1.5, 3.9)

,0.001

2

0.9 (0.2, 3.9)

0.83

0.84

District of residence:
Nyarugenge

45

– REF –

5

– REF –

Gasabo

71

1.6 (1.1, 2.5)

0.02

10

2.1 (0.7, 6.2)

0.19

Kicukiro

76

2.5 (1.7, 3.8)

,0.001

6

1.8 (0.5, 6.0)

0.34

40

0.3 (0.2, 0.5)

,0.001

10

0.9 (0.4, 2.3)

0.86

Never married

130

1.0 (0.6, 1.5)

0.85

16

0.9 (0.3, 2.8)

0.89

Divorced

24

0.7 (0.4, 1.1)

0.13

3

1.0 (0.3, 3.7)

0.95

Currently breastfeeding
Marital status

37

1.8 (1.1, 3.1)

0.03

2

1.3 (0.3, 6.9)

0.75

Used condom at last sex

138

0.9 (0.6, 1.3)

0.49

12

0.4 (0.2, 1.0)

0.06

Cleansed vagina before last sex

100

1.5 (1.1, 2.1)

0.02

12

1.9 (0.8, 4.6)

0.17

Widowed

Years working as sex worker:
#1

29

– REF –

10

– REF –

0.11

2–3

60

0.8 (0.5, 1.4)

0.51

4

0.4 (0.1, 1.4)

0.13

4–5

35

0.9 (0.5, 1.6)

0.67

4

0.7 (0.2, 2.7)

0.61

$6

54

1.0 (0.6, 1.9)

0.90

3

0.5 (0.1, 2.2)

0.37

72

2.2 (1.5, 3.2)

,0.001

8

2.3 (0.9, 5.8)

0.07

,20

31

0.7 (0.4, 1.2)

0.16

4

2.3 (0.4, 12.7)

0.34

20–39

57

0.9 (0.6, 1.4)

0.60

10

3.6 (0.8, 16.9)

0.10

40–59

42

0.9 (0.5, 1.5)

0.65

4

2.0 (0.4, 10.9)

0.44

2

–REF–

0.45

1

1.0 (0.1, 11.2)

History of forced sex
No. vaginal sex acts in past month:

60–89

45

– REF –

$90

17

0.8 (0.4, 1.5)

1.0

No. clients per week in last month:
,5

31

0.7 (0.4, 1.2)

0.14

5

2.1 (0.4, 11.2)

0.37

5–9

59

1.1 (0.7, 1.8)

0.75

9

3.2 (0.7, 15.1)

0.14

10–15

52

0.9 (0.6, 1.5)

0.69

4

1.3 (0.2, 7.2)

0.77

16–25

39

– REF –

2

–REF–

.25

10

0.7 (0.3, 1.6)

0.38

1

1.2 (0.1, 13.3)

11

0.5 (0.3, 1.0)

0.05

1

0.4 (0.1, 3.3)

Have an HIV+ sex partner

0.90

No. lifetime HIV tests:
None

97

– REF –

7

–REF–

1

64

0.6 (0.4, 0.9)

0.02

5

0.6 (0.2, 1.9)

0.39

$2

31

0.3 (0.2 0.5)

,0.01

9

1.1 (0.4, 3.1)

0.82

HIV tested in past 6 months

4

0.2 (0.1, 0.5)

,0.001

1

0.3 (0.1, 2.4)

0.27

Had $1 genital symptom in last month

50

1.5 (1.0, 2.2)

0.05

7

1.9 (0.7, 4.8)

0.20

Sought STI treatment in last 3 months

34

2.2 (1.3, 3.5)

,0.01

6

3.8 (1.4, 10.3)

,0.01

Regular alcohol consumption

120

1.5 (1.0, 2.1)

0.03

9

0.6 (0.3, 1.5)

0.31
0.25

History of imprisonment

89

1.7 (1.2, 2.4)

0.01

6

0.6 (0.2, 1.5)

HSV-2 seropositive

167

7.9 (4.5, 13.8)

,0.001

20

17.0 (2.3, 128.6)

,0.01

Currently pregnant

10

0.6 (0.3, 1.1)

0.11

2

1.0 (0.2, 4.4)

0.97

doi:10.1371/journal.pone.0024321.t004
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Table 5. Factors associated with prevalent and recent HIV infection among female VCT clients, Kigali, Rwanda.

Risk factor

No. HIV+
(Total N = 161)

Adjusted Odds
Ratio (95% CI)

P value

No. Recent
Infection
(N = 20)

Adjusted Odds
Ratio (95% CI)

P value

Current age (in years):
18–24

48

– REF –

7

– REF –

25–29

37

1.2 (0.8, 2.0)

0.35

3

0.7 (0.2, 2.7)

0.59

30–34

33

2.7 (1.7, 4.4)

,0.001

2

1.1 (0.2, 5.5)

0.89

$35

43

2.2 (1.4, 3.5)

,0.001

8

2.8 (1.0, 7.9)

0.05

District of residence:
Nyarugenge

55

– REF –

5

– REF –

Gasabo

62

0.5 (0.3, 0.8)

,0.01

8

0.3 (0.1, 0.9)

0.03

Kicukiro

41

0.9 (0.6, 1.4)

0.58

7

0.7 (0.2, 1.9)

0.44

Outside Kigali city

3

0.2 (0.1, 0.7)

,0.01

0

NA

Currently breastfeeding

31

0.8 (0.5, 1.3)

0.34

7

1.9 (0.7, 5.0)

0.18

Currently married

66

1.0 (0.7, 1.5)

0.84

12

2.7 (1.1, 6.9)

0.04

Never married

44

0.6 (0.4, 0.9)

,0.01

2

0.1 (0.03, 0.6)

,0.01

Divorced

32

1.8 (1.1, 2.8)

0.01

4

1.8 (0.6, 5.9)

0.31

Marital status

19

1.2 (0.7, 2.2)

0.56

2

0.6 (0.1, 2.8)

0.48

Used condom at last sex

Widowed

33

2.1 (1.4, 3.3)

,0.001

2

0.9 (0.2, 3.9)

0.86

Cleansed vagina before last sex

10

1.0 (0.5, 2.0)

1.0

4

3.4 (1.0, 11.5)

0.05

History of forced sex

32

0.9 (0.6, 1.4)

0.78

2

0.4 (0.1, 1.8)

0.24

No. vaginal sex acts in past month:
0

66

– REF –

6

– REF –

1–5

45

1.6 (1.0, 2.4)

0.03

6

2.3 (0.7, 7.3)

0.16

6–15

36

1.3 (0.9, 2.1)

0.20

6

2.9 (0.9, 9.3)

0.08

$16

14

0.8 (0.4, 1.5)

0.46

2

1.4 (0.3, 7.0)

0.70

11

3.4 (1.6, 7.6)

,0.01

1

2.7 (0.3, 23.3)

0.36

Have an HIV+ sex partner
No. lifetime HIV tests:
None

56

– REF –

3

– REF –

1

47

0.7 (0.5, 1.1)

0.17

4

1.2 (0.3, 5.3)

0.84

2

25

0.4 (0.2, 0.7)

,0.001

2

0.6 (0.1, 3.8)

0.61

3

14

0.3 (0.2, 0.6)

,0.001

2

1.0 (0.2, 6.3)

0.98

$4

17

0.3 (0.2, 0.6)

,0.001

9

3.9 (1.0, 15.2)

0.05

19

0.5 (0.3, 0.7)

,0.01

3

0.6 (0.2, 2.1)

0.43
0.36

HIV tested in past 6 months
Had $1 genital symptom in last month

53

2.5 (1.7, 3.6)

,0.001

5

1.6 (0.6, 4.6)

Sought STI treatment in last 3 months

27

2.1 (1.3, 3.5)

,0.01

4

2.4 (0.7, 7.4)

0.15

Regular alcohol consumption

20

1.0 (0.6, 1.8)

0.88

1

0.4 (0.1, 2.9)

0.34

History of imprisonment

21

2.7 (1.6, 4.7)

,0.001

2

1.6 (0.4, 7.1)

0.56

HSV-2 seropositive

135

3.1 (2.4, 4.0)

,0.001

18

3.8 (1.7, 8.2)

,0.001

Currently pregnant

19

1.1 (0.7, 1.9)

0.68

0

NA

NA

doi:10.1371/journal.pone.0024321.t005

tive safety and effectiveness (data not shown). All pregnant, HIVinfected women in both groups were referred to a PMTCT
program for care.
This study has a number of strengths, including rapid accrual of
an at-risk, hard-to-reach group (FSW), and documentation of HIV/
STI prevalence rates, and collection of in-depth demographic and
behavioral information, in two epidemiologically important but
understudied groups. Study limitations are also noted. Data on risk
behaviors are based on self-report, and therefore subject to bias.
Recruitment methods for FSW, including eligibility criteria and lack

with husbands or steady partners, and VCT clients reported very
low levels of condom use with casual partners. Condom
distribution and education campaigns should be scaled up for
Rwandan FSW and other women in potentially risky partnerships
of all types (marital, steady, or casual). Participants’ use of
contraceptive methods other than condoms was low, although
somewhat higher than the DHS+ rate (9.6%) [5]. Our participants
reported waiting for menses to return after childbirth and fear of
side effects as main reasons for not using contraception,
demonstrating an acute need for education regarding contracepPLoS ONE | www.plosone.org
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of statistical representativeness of the sample to the FSW population
in Kigali, may reduce the generalizability of HIV prevalence and
other data. VCT clients are a self-selected group and comparisons
with the general population (e.g., DHS sample) are therefore
difficult. A small number in both study groups with recent infection
prohibited a more thorough statistical explanation. Finally, while
VCT clients were asked about engagement in transactional sex,
interview data are not able to distinguish self-declared FSW among
the VCT population.
Our population-based survey reveals a high HIV burden—both
in terms of prevalent and recently acquired infection—among
female sex workers and VCT clients in urban Kigali, the scale of
which is masked by the relatively low general-population HIV
prevalence in Rwanda. Timely and comprehensive data such as
these on HIV prevalence, recent HIV infection and their
correlates should benefit those responsible for maintaining and
strengthening HIV/AIDS surveillance in Rwanda, as well as those
planning prevention interventions among at-risk groups.
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